VF
GENE

Virtu Financial’s Genetic Technologies Ltd. GENE Stock Holding History

Virtu Financial’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,636
Closed -$15K – 2093
2023
Q2 		$15K Buy
3,636
+463
+15% +$2.29K ﹤0.01% 1312
2023
Q1 		$19K Buy
+3,173
New +$18.6K ﹤0.01% 1256
2022
Q2 		– Sell
-2,062
Closed -$20K – 2217
2022
Q1 		$20K Buy
+2,062
New +$20K ﹤0.01% 1299
2021
Q4 		– Sell
-2,671
Closed -$41K – 2295
2021
Q3 		$41K Buy
+2,671
New +$45.8K ﹤0.01% 1301
2020
Q4 		– Sell
-4,791
Closed -$83K – 1889
2020
Q3 		$83K Buy
4,791
+1,253
+35% +$23.3K 0.01% 745
2020
Q2 		$40K Buy
+3,538
New +$36.1K ﹤0.01% 1036
2019
Q3 		– Sell
-1,354
Closed -$16K – 1934
2019
Q2 		$16K Buy
+1,354
New +$20.8K ﹤0.01% 1365
2018
Q2 		– Sell
-1,875
Closed -$39K – 2613
2018
Q1 		$39K Buy
+1,875
New +$54.2K ﹤0.01% 1752

Other funds holding GENE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
SA
Scarborough Advisors Annapolis, Maryland $914M AUM 17.4% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
PWA
Provenance Wealth Advisors Fort Lauderdale, Florida $945M AUM 17.16% 1-Year Est. Return

Virtu Financial's GENE Position: Q3 2023 in Review

Virtu Financial sold out of Genetic Technologies Ltd. (GENE) in Q3 2023, closing a stake of 3,636 shares — an estimated $15K sold.

Virtu Financial first reported a position in GENE in Q1 2018 and held it in 8 quarters. The position peaked at $83K in Q3 2020. 6 funds tracked by Wall St. Rank hold GENE as of Q3 2023.

  • Virtu Financial reported no remaining Genetic Technologies Ltd. position as of Q3 2023 after selling out during the quarter.
  • Virtu Financial sold 3,636 Genetic Technologies Ltd. shares in Q3 2023, an estimated $15K.
  • Virtu Financial first reported a position in Genetic Technologies Ltd. in Q1 2018 and held it in 8 quarters.
  • Virtu Financial's Genetic Technologies Ltd. position peaked at $83K in Q3 2020.
  • 6 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q3 2023.

Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.